DDR1 and lung adenocarcinoma: Furthermore, in KRAS-mutant lung adenocarcinoma, combined inhibition of DDR1 and Notch signaling resulted in regression of patient-derived xenografts with an efficacy comparable to standard chemotherapy [30].